Illinois Tool Works Inc.

(New York Stock Exchange)
Back to all articles
Bullish +55

Illinois Tool Works (ITW): Innovation Gains or an Industrial Upturn?

Company update Financial outlook AI-generated analysis

πŸ“ˆ Organic revenue growth accelerated from 0.4% in Q1 to 4.5% in Q2 driven by recovering equipment investment.

πŸ’° Management raised 2026 GAAP EPS midpoint to $11.45, implying approximately 9% growth against 2025 EPS of $10.49.

πŸ“Š Second-quarter operating margin increased 40 basis points to 26.7%, with enterprise initiatives contributing 120 basis points.

πŸ’΅ First-half non-GAAP free cash flow rose to $1.16 billion, representing approximately 14% of revenue.

⚠️ Cash conversion reached only 73% of net income in the first half against a full-year target above 100%.

🏦 Debt increased to $9.69 billion from $8.97 billion, raising financing demands for sustaining the multiple.

πŸ”¬ Management attributed 2.4 percentage points of 2025 revenue growth to customer-backed innovation despite flat organic revenue overall.

πŸ“‰ Growth remains uneven with Automotive OEM declining 0.4% and Food Equipment remaining flat in Q2.

🀝 The company carries a nearly 3% dividend yield, placing it on the retirement stock portfolio list.

πŸ” Peer comparison shows ITW's 26.7% operating margin versus Dover Corporation's 17.9%, though ITW has higher debt.

Bullish Signals
  • Organic revenue growth accelerated from 0.4% in Q1 to 4.5% in Q2 driven by recovering equipment investment.
  • Management raised 2026 GAAP EPS midpoint to $11.45, implying approximately 9% growth against 2025 EPS of $10.49.
  • Second-quarter operating margin increased 40 basis points to 26.7%, with enterprise initiatives contributing 120 basis points.
  • First-half non-GAAP free cash flow rose to $1.16 billion, representing approximately 14% of revenue.
  • Pricing increases in the quarter exceeded higher raw-material costs in dollars, creating value for customers.
  • The company carries a nearly 3% dividend yield, placing it on the retirement stock portfolio list.
Risk Factors
  • Cash conversion reached only 73% of net income in the first half against a full-year target above 100%.
  • Debt increased to $9.69 billion from $8.97 billion, raising financing demands for sustaining the multiple.
  • Receivables and inventory absorbed $456 million, requiring discipline to turn recovery into distributable cash.
  • Growth remains uneven with Automotive OEM declining 0.4% and Food Equipment remaining flat in Q2.
Full Analysis
Illinois Tool Works Inc. (NYSE: ITW) is experiencing accelerated organic revenue growth, rising from 0.4% in the first quarter to 4.5% in the second quarter, driven by recovering equipment investment. The company maintains a premium valuation with a forward P/E of 22x and a trailing P/E of 25x, supported by strong profitability but requiring sustained cash generation to justify the multiple. Management raised its 2026 GAAP EPS midpoint to $11.45 from $11.30, implying approximately 9% growth against 2025 EPS of $10.49. Second-quarter operating margins improved by 40 basis points to 26.7%, with enterprise initiatives contributing 120 basis points before other pressures. Pricing increases in the quarter exceeded higher raw-material costs, though timing lags diluted the margin percentage. The company reported a $34 million first-quarter tax benefit and approximately 2% fewer diluted shares in the first half of the year. First-half non-GAAP free cash flow increased to $1.16 billion from $945 million, representing approximately 14% of revenue compared to 7.5% for peer Dover Corporation. However, cash conversion reached only 73% of net income against a full-year target above 100%, as receivables and inventory absorbed $456 million. Illinois Tool Works Inc. ended 2025 with debt at $9.69 billion, up from $8.97 billion, increasing financing demands. While organic growth guidance of 3%–4% represents a stronger revenue backdrop than the flat 2025 result, growth remains uneven across segments like Welding and Test & Measurement versus Automotive OEM. The investment case relies on innovation generating returns after continuing R&D costs and sustaining cash conversion above 100% to support the valuation.